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AbstrACt
Introduction A number of observational studies have 
indicated that poststroke depression could increase 
the risk of stroke outcomes. There is a meta-analysis 
indicating that poststroke depression is a risk factor 
of all-cause mortality. This paper reports the protocol 
for a systematic review and meta-analysis to clarify 
the associations of poststroke depression with stroke 
recurrence and mortality in order to determine whether 
poststroke depression is a predictor of stroke outcomes 
according to data extracted from relevant observational 
studies.
Methods and analysis MEDLINE, Web of Science 
databases, EMBASE, Cochrane Central Register of 
Controlled Trials, Cochrane Database of Systematic 
Reviews will be used to conduct the search. Published 
studies written in English will be included. The risk of 
bias for the studies included in the systematic review or 
meta-analysis will be assessed by the Newcastle–Ottawa 
Quality Assessment Scale. HRs for stroke recurrence 
and mortality with 95% CIs will be included as primary 
outcomes. Subgroup analyses and meta-regression will be 
performed.
Ethics and dissemination Ethics approval will not be 
needed because the data used in this systematic review 
will be extracted from published studies. The results of the 
systematic review focusing on whether depression after 
stroke is a predictor for stroke recurrence and mortality 
will be disseminated by publication in a peer-reviewed 
journal.
PrOsPErO registration number CRD42018107944.
IntrOduCtIOn 
Stroke, also called cerebrovascular accident, 
is a leading cause of long-term disability and 
the fourth most common cause of death. 
Established risk factors for stroke include 
high plasma cholesterol, high blood pressure, 
diabetes, atrial fibrillation, race, smoking 
and older age.1 Stroke has been reported to 
produce increased oxidative stress which is 
closely associated with the development of 
psychiatric symptoms.2 
Poststroke depression (PSD), whose major 
symptoms are melancholia, dysphoria and 
vegetative signs such as sleep disorders, 
reduced libido and energy level,3–5 is a 
significant neuropsychiatric manifestation as 
it predicts poor outcomes after stroke such 
as limitations in daily activities,6 cognitive 
disorders,7 8 poor rehabilitation outcomes 
and social isolation. PSD has a prevalence 
of approximately 30% in unselected stroke 
survivors based on the results of two previous 
meta-analyses.9 10
Several recent observational studies, 
including prospective/retrospective cohort 
studies, have assessed the association between 
PSD and subsequent risks of stroke morbidity 
and mortality11–17; however, the results of 
these studies are inconsistent. There is only 
one previous meta-analysis including 13 
studies indicating that depression after stroke 
is closely associated with increased risk of 
all-cause mortality.18 Notably, there is a lack of 
a robust meta-analysis focusing on the impact 
of PSD on stroke recurrence and mortality 
based on all related studies.
ObjECtIvE
The protocol study is designed to establish 
an explicit methodology for conducting a 
systematic review and meta-analysis, the aims 
of which comprise:
1. Clarification of the relationship between 
depression and stroke recurrence as well 
as mortality in the poststroke patient 
strengths and limitations of this study
 ► The meticulous design and use of standardised 
study rating instruments.
 ► Compliance with all relevant guidelines for system-
atic reviews and meta-analyses.
 ► Different designs and participants’ characteristics of 
all the included studies will lead to high heterogene-
ity that may limit the quality of the evidence of this 
meta-analysis and systematic review.
 ► Limitations will be minimised and strengths en-
hanced in order to achieve a robust estimation of 
the association of interest.
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population according to data from observational 
studies.
2. The analysis of PSD as a predictor of stroke recurrence 
and mortality.
MEthOds And AnAlysIs
review design
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses Protocols (PRISMA-P)19 will be set as a 
guide book for the protocol, and the review methods 
will be designed based on the Meta-analysis of observa-
tional studies in epidemiology: a proposal for reporting,20 
PRISMA21 and Cochrane Collaboration Handbook.
search strategy
We will conduct the literature search using Medline (via 
PubMed), Web of Science databases, EMBASE, Cochrane 
Central Register of Controlled Trials and the Cochrane 
Database of Systematic Reviews. Articles published will be 
searched until the meta-analysis is finished. As shown in 
table 1, the first theme is PSD, the second theme is stroke 
and the third theme is observational study. The exploded 
versions of Medical Subject Headings of each theme will 
be included. All the three search themes will be combined 
using the Boolean operator ‘and’.
Inclusion criteria
All observational studies on the association between PSD 
and stroke recurrence outcomes that meet the following 
criteria will be included:
1. Prospective or retrospective observational studies.
2. Studies that include stroke outcomes such as ischaemic 
stroke, haemorrhagic stroke, transient ischemic attacks 
(TIA), stroke mortality and all-cause mortality.
3. Depression will be ascertained using an appropriate 
instrument which might include (but will not be lim-
ited to) WHO International Classification of Diseases 
(WHO ICD) or Diagnostic and Statistical Manual of 
Mental Disorders codes, or research scales such as the 
Center for Epidemiologic Studies Depression Scale, 
Patient Health Questionnaire-9, Hospital Anxiety and 
Depression Scale and Hamilton Depression Rating 
Scale; alternatively unstructured physician-assigned 
diagnoses may be used. History of stroke or stroke re-
currence may be diagnosed using (but not limited to) 
WHO ICD codes, National Institutes of Health Stroke 
Scale (NIHSS) or by physician-assigned codes.
4. Outcomes measured using univariate and multivariate 
Cox proportional hazards models.
5. Population of adults aged ≥18.
6. Studies published in English.
The PRISMA flow chart shows the process of study 
selection (figure 1).
data collection and management
We will use Endnote (V.x7) to manage the search results 
and perform screening. The data will be extracted on 
Microsoft Excel 2007, and statistical analysis will be 
carried out using STATA V.13 and Review Manager V.5.3 
software.
data extraction
According to the inclusion criteria, titles and abstracts will 
be independently checked by two reviewers to identify 
eligible studies. After that, the full manuscripts of the iden-
tified studies will be examined by two researchers who will 
finally determine the included and excluded studies and 
clarify the reasons of exclusion. A third researcher will be 
asked to check, with discussion and consensus sought in 
cases of disagreement. Two researchers will independently 
extract the data on author information, publication year, 
country, follow-up years, number/age/gender of partici-
pants, the number of individuals with the outcome based 
on the exposure (number of deaths in individuals with 
depression and number of deaths in individuals without 
depression), the main exposure definition(s) (depres-
sion scales or clinician diagnosis), the main outcome 
definition(s) (stroke recurrence morbidity or mortality, 
types), the size of the association (HRs with 95% CI) 
and factors adjusted for, multiple models if reported, 
the account taken of important confounders including 
setting (institutionalised vs community-dwelling), depres-
sion measurement time points, stroke severity and activi-
ties of daily living. A data extraction sheet will be made to 
Table 1 Proposed search terms
Theme Search terms
Poststroke depression ‘post stroke depression’
OR ‘post stroke depressive 
disorder’
OR ‘depression after stroke’
OR ‘depressive disorder after 
stroke’
Stroke ‘stroke’
OR ‘cerebrovascular accident’
OR ‘cerebrovascular disease’
OR ‘cerebral ischemia’
OR ‘ischemic stroke’
OR ‘hemorrhagic stroke’
OR ‘Transient Ischemic Attacks’
OR ‘mortality’
OR ‘all-cause mortality’
OR ‘stroke mortality’
OR ‘cerebrovascular mortality’
OR ‘death’
OR ‘stroke death’
OR ‘cerebrovascular death’
Observational study ‘observational study’
OR ‘prospective cohort study’
OR ‘retrospective cohort study’
OR ‘population-based study’
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include all the information mentioned above, and it may 
be adapted during the extraction process in case relevant 
information is lacking. Authors of the included studies 
will be contacted in case of missing key information.
Outcomes and prioritisation
The primary outcome of the meta-analysis is first 
recorded stroke recurrence or death with PSD diagnosis. 
Observational studies that calculate effect estimates as 
HRs are eligible in our meta-analysis. Where included 
studies report associations between continuous scores 
and the outcome (such as HR of stroke recurrence per 
point increase in a depression scale score), those HRs will 
be included in subgroup analysis according to different 
severity levels of depression assessed by scale scores. Types 
of stroke (ischaemic or haemorrhagic) and causes of 
mortality (stroke-related or all-cause) will be categorised.
risk of bias assessment in the included studies
All the included studies will be assessed by the Newcastle–
Ottawa Quality Assessment Scale adapted for cohort 
studies, the score range of which is 0–9. Studies with 
scores ≥7 are conventionally considered as high quality. 
Two researchers will conduct study quality assessments 
independently. Any disagreement will be resolved 
by consultation with a third researcher or by group 
discussion.
data synthesis
A table will be created to summarise characteristics 
of the included studies. After the data extraction has 
been completed, researchers will determine the possi-
bility of conducting a meta-analysis. A meta-analysis will 
be conducted if at least six observational studies using 
HRs for stroke outcomes and mortality are included. 
The extracted HRs with 95% CIs will be combined 
by using a random-effects model if it is possible to 
conduct a meta-analysis. The heterogeneity of the 
studies will be measured with an I2 value (I2 values 
of <25%, 25%–50% and >50% represent low, medium 
and high heterogeneity, respectively22). Adjusted and 
unadjusted estimates will be compared separately for 
each outcome. The pooled HRs and 95% CIs will be 
the primary outcome of the meta-analysis. A narrative 
synthesis will be taken if a meta-analysis is not possible. 
Visual assessment of the funnel plot and Egger’s test 
will be used to assess publication bias.23 The Grading of 
Recommendations Assessment, Development and Eval-
uation tool will be used to evaluate the strength of the 
evidence body.24
In order to clarify major factors underlying any high 
heterogeneity, subgroup analyses and meta-regres-
sion will be performed according to the duration of 
follow-up (above/below median years), stroke severity 
(low, moderate, severe according to NIHSS), defini-
tion of depression (WHO ICD codes, scales, physician 
diagnosis), study setting (institutionalised vs communi-
ty-dwelling), bias score (above/below median scores), 
the stroke recurrence outcome type (ischaemic stroke, 
haemorrhagic stroke), mortality type (stroke-specified, 
all-cause), mean age (above/below median years old)/
male proportion of study participants (above/below 
median %) and sample size (above/below median 
numbers). Sensitivity analyses will be conducted by 
excluding studies one by one and comparing the results 
in the analysis.
Patient and public involvement
No patients will be involved in this study.
Figure 1 The Preferred Reporting Items for Systematic Reviews and Meta- Analyses flow chart of study selection.
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dIsCussIOn
PSD as a predictor of stroke recurrence and mortality 
remains to be confirmed by an updated meta-analysis 
because the last one, to our knowledge, was carried out 
5 years ago.18 Thus, a meta-analysis and systematic review 
will be designed by us to determine whether the risk of 
stroke recurrence and mortality outcomes is relatively 
high in people with PSD.
Strengths and limitations will be highlighted in the 
process of identified evidence. The meticulous design, the 
use of standardised study rating instruments and compli-
ance with all relevant guidelines for systematic reviews 
and meta-analyses are anticipated strengths. Limitations 
will mainly originate from different designs and charac-
teristics of all the included studies; this may lead to high 
heterogeneity which will in turn lower the quality of the 
evidence of this meta-analysis and systematic review; 
however, this may be overcome by including subgroup 
analyses and meta-regression in the meta-analysis.
Significantly, the association between PSD and stroke 
recurrence and mortality will be clarified in the results of 
the designed meta-analysis and systematic review, seeking 
to minimise its limitations and enhance its strengths, as 
mentioned.
Ethics and dissemination
There will be no concerns about privacy. The systematic 
review will focus on whether PSD is a predictor for stroke 
recurrence and mortality outcomes, the results of which 
will be disseminated by publication in a peer-reviewed 
journal after completion.
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